beta-hydroxybutyrate restrains colitis-associated tumorigenesis by inhibiting HIF-1alpha-mediated angiogenesis. Huang C, Tan H, Wang J, Huang L, et al. Cancer Lett 2024;593:216940.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang C, Tan H, Wang J, Huang L, et al. beta-hydroxybutyrate restrains colitis-associated tumorigenesis by inhibiting HIF-1alpha-mediated angiogenesis. Cancer Lett 2024;593:216940.
PMID: 38729554